Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study.

BACKGROUND Mechanisms of recurrence after treatment of in-stent restenosis are unknown. METHODS AND RESULTS We prospectively performed quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) in 37 lesions with Palmaz-Schatz stents enrolled in a study of intracoronary radiation for in-stent restenosis. Primary treatment was at the discretion of the operator: PTCA (n=8) or ablation+adjunct PTCA (n=29). Lesions were studied before intervention, immediately after primary intervention, and 42+/-8 minutes later. QCA measurements included minimal luminal diameter and diameter stenosis. Planar IVUS measurements included arterial, stent, lumen, and in-stent tissue areas. Stent, lumen, and in-stent tissue volumes were calculated by use of Simpson's rule. Compared with immediately after intervention, the delayed (42+/-8 minutes) minimal lumen area decreased by 20% (5.8+/-1.9 to 4.5+/-1.3 mm2, P<0.0001) and the lumen volume by 12% (58+/-41 to 52+/-37 mm3, P=0.0001). Ten lesions (27%) had a > or = 2.0-mm2 decrease in minimum lumen area. Lumen loss (1) resulted from increased tissue with the stent, (2) correlated with lesion length and preintervention in-stent tissue, and (3) was not seen angiographically. CONCLUSIONS There is significant tissue reintrusion shortly after catheter-based treatment of in-stent restenosis. This was greater in longer lesions and those with a larger in-stent tissue burden, was not reflected in the QCA measurements, and may contribute to recurrence.

[1]  M. Leon,et al.  Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. , 1997, Circulation.

[2]  C Di Mario,et al.  Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. , 1997, Journal of the American College of Cardiology.

[3]  E. Regar,et al.  Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response. , 1997, Circulation.

[4]  M. Leon,et al.  Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. , 1996, Circulation.

[5]  M. Leon,et al.  Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. , 1996, The American journal of cardiology.

[6]  M. Leon,et al.  In vivo validation of intravascular ultrasound length measurements using a motorized transducer pullback system. , 1996, The American journal of cardiology.

[7]  M. Nobuyoshi,et al.  Long-term clinical and quantitative angiographic follow-up after the Palmaz-Schatz stent restenosis , 1996 .

[8]  M. Leon,et al.  Reproducibility of the intravascular ultrasound assessment of stent implantation in saphenous vein grafts. , 1995, The American journal of cardiology.

[9]  Y. Oka,et al.  Increased susceptibility of angiographically smooth left anterior descending coronary artery to an impairment of vasoresponse to acetylcholine, and the relation between impaired vasoresponse and low-density lipoprotein cholesterol level. , 1995, The American journal of cardiology.

[10]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[11]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[12]  M. Leon,et al.  Patterns of in-stent restenosis Classification and impact on subsequent target lesion revascularization , 1998 .

[13]  Stanton A. Glantz,et al.  Primer of biostatistics : statistical software program version 6.0 , 1981 .